Niu S, Li Y, Shao H, Hu J, et al. Phase II clinical trial of simultaneous-boost IMRT with three dose gradients in patients with stage I-II nasal type natural killer/T-cell lymphoma: long-term outcomes of survival and quality of life: Simultaneous-boost intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 2023 Nov 6:S0360-3016(23)07944.
PMID: 37939733